Medicine Shortages: Gaps Between Countries and Global Perspectives

Acosta, Angela, Vanegas, Egdda Patricia, Rovira, Joan, Godman, Brian, Bochenek, Tomasz·2019·Frontiers in Pharmacology
DOI 10.3389/fphar.2019.00763

Cited by (154)

Items 101–154 of 154

  1. Assessing Relationships Between Drug Shortages in the United States and Other Countries
    Andrew W. Mulcahy, Preethi Rao, Vishnupriya Kareddy, Denis M. Agniel, Levin, Jonathan S., Daniel Schwam · 2021 · RAND Corporation eBooks
  2. Drug Shortages and Its Effects on Service Delivery among Key Informants (KIs) in Fiji
    Asaeli Raikabakaba, Masoud Mohammadnezhad, Ledua Tamani, Devina Gaundan · 2022 · Global Journal of Health Science
  3. Opinions of pharmacists in Turkiye on drug shortages and effects on treatment
    Muammer ÇALIKUŞU, Gülbin Özçelikay · 2024 · Hacettepe University Journal of the Faculty of Pharmacy
  4. Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries With a Particular Focus on Africa and the Implications
    AISDL · 2021
  5. Editorial: Pharmaceutical policy, impact and health outcomes
    Hye-Young Kwon, Brian Godman · 2023 · Frontiers in Pharmacology
  6. Prescribing Competence of Canadian Medical Graduates: National Survey of Medical School Leaders
    Anne Marie Holbrook, Simran Lohit, Oswin Chang, Jiawen Deng, Dan Perri, Gousia Dhhar, Mitchell Levine, Jill C. Rudkowski, Heather McLeod, Kaitlynn Rigg et al. · 2024 · International Medical Education
  7. Perceptions, attitudes and experiences of hospital pharmacists working in the private sector regarding drug shortage in Lebanon: a national cross-sectional study
    Hadi Hallal, Maha Hoteit, S. Hallit, Mahmoud Hallal · 2025 · Journal of Pharmaceutical Policy and Practice
  8. From 60 Causes to 10 Solutions Against Antibiotics Shortages in Sweden: Platinea’s Approach to Developing Policy Interventions
    Enrico Baraldi, Håkan Hanberger, Sofia Wagrell · 2025 · Antibiotics
  9. Medicines availability in Ecuador's public system (2015–2024): a policy design analysis of financing, public procurement, and governance
    Alejandro Hernández-Luis, Guillaume Fontaine, José Luis Morales · 2026 · The Lancet Regional Health - Americas
  10. Catastrophic out of pocket medicine expenditure: A case for monitoring performance of primary providers on national health insurance scheme
    Paul Otor Onah · 2023 · Nigerian Journal of Pharmacy
  11. A Survey on Medicine Shortage in Community Pharmacies in Yogyakarta Province, Indonesia
    Susi Ari Kristina, Tri Murti Andayani, Dwi Endarti, Anna Wahyuni Widayanti, Agatha Losita Candradewi Pertiwi · 2024 · INDONESIAN JOURNAL OF PHARMACY
  12. Global Medicine Shortages: Public Health Challenges and Policy Responses
    Carlos Alberto Corona-Arias, Ricardo Daniel Corona González, Amy Scarlet Martínez Salto, Manuel Maximiliano Paredes Ydiaquez, Richard Adrián Vergara Trujillo, Estefany Yetlanetzi Castañeda López, Sebastian Guardiola Segovia, Erwin Giovanny Mercado Estrada · 2025 · SAGA Revista Científica Multidisciplinar
  13. ON THE AVAILABILITY OF MEDICINES: INTERNATIONAL EXPERIENCE AND THE SITUATION IN KAZAKHSTAN
    РОО «Профессиональная ассоциация клинических фармакологов и фармацевтов», Астана, Казахстан, Н.Т. Алдиярова, Р.С. Кузденбаева, РОО «Профессиональная ассоциация клинических фармакологов и фармацевтов», Астана, Казахстан, РГП на ПХВ «Национальный центр экспертизы лекарственных лекарств и медицинских изделий» МЗ РК, Алматы, Казахстан, Larissa Makalkina, НАО «Медицинский университет Астаны», Астана, Казахстан · 2026 · Farmaciâ Kazahstana
  14. Drug shortages in Latin America: A cross-sectional survey on impact and mitigation in pharmacy and procurement
    Ernesto Martínez Vargas, Arturo Villalobos-Madriz, Sebastián Arguedas‐Chacón, Dadier Antonio Arroyo Monterroza, Antonella Milano Gil, Vania Teixeira, Jorge Morales Vallespín, Silvestre Dalmaso‐Neto, Cesar Sanchez‐Solis, Esteban Zavaleta‐Monestel et al. · 2026 · The Journal of Medicine Access
  15. Strategies for addressing the shortage of medicines to improve service delivery
    Nkaelang Modutlwa · 2024 · International Journal of Innovation in Management Economics and Social Sciences
  16. Sick to the stomach of the ranitidine shortage?
    Marco Motta, Mike Wilcock · 2021 · Prescriber
  17. Evaluation of the establishment of a national task force – A systematic measure to manage critical drug shortages in hospitals
    Joo Hanne Poulsen, Stine Raaby Jensen, Marianne Hald Clemmensen, M Vasehus Holck, Nina Uldal, Trine Kart, Gitte Nordendorff Nielsen, Helle Byg Armandi, og Lecia Møller Hansen · 2023 · Exploratory Research in Clinical and Social Pharmacy
  18. A Case Study of the Registration of Essential Medicines in the East African Community
    Alexander Karl Green, Petra Brhlíková, Moses Ocan, Allyson M Pollock · 2021 · Research Square
  19. Time to Invest in Medicines Resilience
    Ravina Barrett · 2020 · Journal of Illicit Economies and Development
  20. Drug shortages in a state-owned academic hospital during the COVID-19 pandemic in Ecuador
    Jorge Luís Vélez-Páez, Diego E. Salazar-Erazo, Juan P. Castelo-Vigme, Andrea C. Jiménez-Arias, Verónica M. Cevallos-Vique, Lisandro Fernández, Carlos E. Durán, Aquiles Rodrigo Henriquez-Trujillo · 2021 · Research Square
  21. Additive manufacturing in community pharmacies: a framework for business model innovation
    Carsten Feldmann, Olaf Rose · 2021 · BMJ Innovations
  22. Application of Continuous‐Flow Processing in Multistep API and Drug Syntheses
    Faith M. Akwi, Paul Watts · 2022 · Methods and principles in medicinal chemistry
  23. Towards a Basis for Policy Framework for Stockouts and Shortages of Drugs
    Alvin Carlo Calucin · 2023 · International Conference on Industrial Engineering and Operations Management (IEOM)
  24. PUBLIC HEALTH CRISIS MANAGEMENT THROUGH PUBLIC COMMUNICATIONS
    2023 · Journal of Management Sciences and Applications
  25. Portuguese Global Medicines Access Index 2021: An Indicator to Measure Access to Hospital Medicines
    Sofia Oliveira‐Martins, Miguel Costa Lopes, Alexandra Cardoso dos Santos, Ana Margarida Advinha · 2024 · Value in Health Regional Issues
  26. WITHDRAWN: Post-Brexit implications: Review of marketing authorisations in Malta
    Yvette Anne P. Patrocinio, Janis Vella Szijj, Anthony Serracino‐Inglott, Lilian M. Azzopardi · 2024 · Health Policy OPEN · Retracted
  27. Sécuriser les chaînes d’approvisionnement en produits médicaux après la pandémie
    OCDE · 2024 · Études de l'OCDE sur les politiques de santé
  28. A stratégiai gyógyszerlista szerepe a gyógyszerhiányok megelőzésében és kezelésében hazánkban
    Gergő Merész, Zsófia Nagy, Balázs Batta, Péter Rózsa · 2024 · Orvosi Hetilap
  29. PHARMACISTS’ PERCEPTIONS ON FACTORS CONTRIBUTING TO STOCK-OUTS OF ESSENTIAL MEDICINES AT A TERTIARY HOSPITAL IN SOUTH AFRICA: A QUALITATIVE CROSS-SECTIONAL STUDY.
    Tiisetso Aubrey Chuene, Sogo France · 2024 · Student s Journal of Health Research Africa
  30. Panorama des initiatives
    OECD · 2024 · Études de l'OCDE sur les politiques de santé
  31. Vulnérabilités des chaînes d’approvisionnement en produits médicaux
    OECD · 2024 · Études de l'OCDE sur les politiques de santé
  32. Avant-propos
    OECD · 2024 · Études de l'OCDE sur les politiques de santé
  33. Résumé
    OECD · 2024 · Études de l'OCDE sur les politiques de santé
  34. The Context of Antibiotic Use in Primary Care and the Role of the Community Pharmacist
    Maarten Lambert · 2025
  35. Tackling Drug Shortages: An In-Depth Systematic Review Protocol
    M. Kanan, Reem Alraya, Ahmad K. Aljabri, Baiaan H Alsaadi, Maryam M Althubyani, Sarah H Alamri, A. Alqarni, Y. Alenazi, A. Almutairi, Amani Alshehri et al. · 2025 · Pharmacy in practice
  36. A Vicious Cycle of Access to Excluded Medicines: Evidence from a Qualitative Study
    Haşim Çapar · 2025 · İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi
  37. Made in Europe – assessing the feasibility of reshoring active pharmaceutical ingredient production to Europe
    Verena Knoll, Caroline Steigenberger, Stefan Fischer, Sabine Vogler · 2026 · Health Policy
  38. Modelo Multidimensional de Control Interno para Mitigación de Desabastecimiento en Hospitales Públicos Latinoamericanos: Revisión Conceptual Integradora
    Susana Valeria Mera Domo, Shirley Patricia Valeriano Gurumendi, Francisco Xavier Zambrano Cantos · 2026 · Telos Revista de Estudios Interdisciplinarios en Ciencias Sociales
  39. Navigating Drug Shortages in Obstetric Care
    Gillian Piltch, David Rochelson, Burton Rochelson · 2026 · O&G Open
  40. Stakeholder Perceptions on Innovative Private Pharmacy Distribution Channels and Implications for Medicine Quality in Zambia: A Qualitative Study
    Scott Kaba Matafwali, Virginia Anne Bond, Sian E. Clarke, Harparkash Kaur · 2026 · Global Health Science and Practice
  41. Socioeconomic Determinants of Access to Medicines Among Romanian Patients with Chronic Diseases: A Cross-Sectional Study
    Corina Daniela Negrila, Luana-Maria Gherasie, Sebastian Mihai Armean, Petru Armean · 2026 · Healthcare
  42. Predicting medication shortages: An analysis of supply-side constraints and procurement vulnerability
    Ahmad Mohammad Albogami, Talaat El-Demerdash Ibrahim Shehata Shehata · 2026 · International Journal of ADVANCED AND APPLIED SCIENCES
  43. An Analysis of the Drivers Contributing to Operational Inefficiencies in Zambia’s Pharmaceutical Supply Chain System: A Case Study of the University Teaching Hospital (UTH) Lusaka
    P Mweetwa, Bupe Getrude Mutono-Mwanza · 2026 · African Journal of Commercial Studies
  44. Systemic challenges in the supply and distribution of medicines in conflict-affected areas of Mali: a qualitative study
    Mohamed Ali Ag Ahmed, Mama Konta, Issa Coulibaly, Djénéba Diarra, Hassane Alami, Karina Kielmann, Raffaella Ravinetto · 2026 · Global Health Action
  45. Drug supply shortages and their consequences for the medical profession: a survey in Germany and Austria
    Julia Maria Rotter, Roland Seifert · 2026 · Naunyn-Schmiedeberg s Archives of Pharmacology
  46. Structural drivers of drug shortages and market withdrawal: a longitudinal analysis of the Romanian pharmaceutical market
    Oana - Teodora Chirac, Adriana-Elena Tăerel, Mihaela Dinu, Robert Ancuceanu · 2026 · BMC Health Services Research
  47. Antibiotic Shortages: Pharmacists’ Experiences, Perspectives, and Perceived Clinical Impacts
    Maarten Lambert, Chloé C. H. Smit, Katja Taxis, Lisa Pont · 2026 · Antibiotics
  48. Source-record correlates of limited observed authorisation-holder diversity in marketed archive records with recorded exclusivity expiry
    김하나 · 2026 · Health Policy and Technology
  49. Evaluating the Possibility of Establishing a Pharmacist-Only Medicine Category in Poland
    Youssef Hariri, Hassan Nasser, Fatima Zahra · 2025 · Annals of Pharmacy Education Safety and Public Health Advocacy
  50. Pharmaceutical and medical device supply chain resilience as a pillar of healthcare security: An integrative review and case-informed governance framework
    Jelena Bojković, Dražen Radanović, Dušan Micić, Aleksandra Obradović, Dejana Jovanović Popović · 2026 · Srpski medicinski casopis Lekarske komore
  51. Machine Learning Prediction of New-Onset Pharmaceutical Supply-Demand Instability From National Monitoring Data: Development and Internal Validation Study (Preprint)
    Seung-Bo Lee, Inmyung Song, Yerin Heo, Dong‐Sook Kim · 2026
  52. Geopolitical conflicts and the global pharmaceutical economy: A conceptual analysis of supply chain disruptions and market resilience
    Manikandan Alagumuthu, Viruthika Murali, Saran Ganesan · 2026 · Journal of Generic Medicines The Business Journal for the Generic Medicines Sector
  53. From organizational capabilities to healthcare operational performance: the role of inventory control
    Aamir Rashid, Rizwana Rasheed · 2026 · Strategic Business Research
  54. ДЕФЕКТУРА ЛЕКАРСТВЕННЫХ СРЕДСТВ В КАЗАХСТАНЕ: ФАКТОРЫ И РАННЕЕ ВЫЯВЛЕНИЕ
    М.М. Оразбаева · 2026 · Вестник науки